KALA BIO, Inc. (KALA) has a consensus analyst rating of Buy, based on 9 analysts covering the stock. Of those, 5 recommend buying, 3 recommend holding, and 1 recommend selling.
The analyst consensus price target for KALA is $18.25, representing a +9,420.1% upside from the current price of $0.1917. Price targets range from a low of $1.50 to a high of $35.00.
